Follow
Ulrike Keim
Title
Cited by
Cited by
Year
Complete lymph node dissection versus no dissection in patients with sentinel lymph node biopsy positive melanoma (DeCOG-SLT): a multicentre, randomised, phase 3 trial
U Leiter, R Stadler, C Mauch, W Hohenberger, N Brockmeyer, C Berking, ...
The Lancet Oncology 17 (6), 757-767, 2016
7192016
Epidemiology of skin cancer: update 2019
U Leiter, U Keim, C Garbe
Sunlight, vitamin D and skin cancer, 123-139, 2020
2822020
Incidence, mortality, and trends of nonmelanoma skin cancer in Germany
U Leiter, U Keim, T Eigentler, A Katalinic, B Holleczek, P Martus, C Garbe
Journal of Investigative Dermatology 137 (9), 1860-1867, 2017
2092017
Final analysis of DeCOG-SLT trial: no survival benefit for complete lymph node dissection in patients with melanoma with positive sentinel node
U Leiter, R Stadler, C Mauch, W Hohenberger, NH Brockmeyer, C Berking, ...
Journal of Clinical Oncology 37 (32), 3000-3008, 2019
1982019
Tumor mutation burden and circulating tumor DNA in combined CTLA-4 and PD-1 antibody therapy in metastatic melanoma–results of a prospective biomarker study
A Forschner, F Battke, D Hadaschik, M Schulze, S Weißgraeber, CT Han, ...
Journal for Immunotherapy of Cancer 7, 1-15, 2019
1522019
Acral lentiginous melanoma: a skin cancer with unfavourable prognostic features. A study of the German central malignant melanoma registry (CMMR) in 2050 patients
Y Teramoto, U Keim, A Gesierich, G Schuler, E Fiedler, T Tüting, C Ulrich, ...
British Journal of Dermatology 178 (2), 443-451, 2018
1092018
Time trends in incidence and mortality of cutaneous melanoma in Germany
C Garbe, U Keim, TK Eigentler, T Amaral, A Katalinic, B Holleczek, ...
Journal of the European Academy of Dermatology and Venereology 33 (7), 1272-1280, 2019
642019
Epidemiology of cutaneous melanoma and keratinocyte cancer in white populations 1943–2036
C Garbe, U Keim, S Gandini, T Amaral, A Katalinic, B Hollezcek, P Martus, ...
European Journal of Cancer 152, 18-25, 2021
632021
Improvement of overall survival in stage IV melanoma patients during 2011–2014: analysis of real-world data in 441 patients of the German Central Malignant Melanoma Registry (CMMR)
A Forschner, F Eichner, T Amaral, U Keim, C Garbe, TK Eigentler
Journal of cancer research and clinical oncology 143, 533-540, 2017
522017
Prognosis of patients with stage III melanoma according to American Joint Committee on Cancer Version 8: a reassessment on the basis of 3 independent stage III melanoma cohorts
C Garbe, U Keim, S Suciu, T Amaral, TK Eigentler, A Gesierich, ...
Journal of Clinical Oncology 38 (22), 2543, 2020
492020
Immune checkpoint inhibition therapy for advanced skin cancer in patients with concomitant hematological malignancy: a retrospective multicenter DeCOG study of 84 patients
U Leiter, C Loquai, L Reinhardt, D Rafei-Shamsabadi, R Gutzmer, ...
Journal for immunotherapy of cancer 8 (2), 2020
432020
Prognosis of patients with primary melanoma stage I and II according to American Joint Committee on Cancer Version 8 validated in two independent cohorts: implications for …
C Garbe, U Keim, T Amaral, C Berking, TK Eigentler, L Flatz, A Gesierich, ...
Journal of Clinical Oncology 40 (32), 3741, 2022
422022
Survival of SLNB-positive melanoma patients with and without complete lymph node dissection: A multicenter, randomized DECOG trial.
U Leiter, R Stadler, C Mauch, W Hohenberger, N Brockmeyer, C Berking, ...
Journal of Clinical Oncology 33 (18_suppl), LBA9002-LBA9002, 2015
382015
Distinct clinicopathological and prognostic features of thin nodular primary melanomas: an international study from 17 centers
C Dessinioti, N Dimou, AC Geller, A Stergiopoulou, S Lo, U Keim, ...
JNCI: Journal of the National Cancer Institute 111 (12), 1314-1322, 2019
362019
Serial or parallel metastasis of cutaneous melanoma? A study of the German central malignant melanoma registry
M Gassenmaier, TK Eigentler, U Keim, M Goebeler, E Fiedler, G Schuler, ...
Journal of Investigative Dermatology 137 (12), 2570-2577, 2017
342017
Sentinel lymph node dissection in head and neck melanoma has prognostic impact on disease-free and overall survival
U Leiter, TK Eigentler, HM Häfner, M Krimmel, U Uslu, U Keim, B Weide, ...
Annals of surgical oncology 22, 4073-4080, 2015
342015
Effectiveness of carboplatin and paclitaxel as first-and second-line treatment in 61 patients with metastatic melanoma
A Pflugfelder, TK Eigentler, U Keim, B Weide, U Leiter, K Ikenberg, ...
PloS one 6 (2), e16882, 2011
342011
Diffuse PRAME expression is highly specific for thin melanomas in the distinction from severely dysplastic nevi but does not distinguish metastasizing from non-metastasizing …
M Gassenmaier, M Hahn, G Metzler, J Bauer, AS Yazdi, U Keim, C Garbe, ...
Cancers 13 (15), 3864, 2021
322021
Immunotherapy plus surgery/radiosurgery is associated with favorable survival in patients with melanoma brain metastasis
T Amaral, I Tampouri, T Eigentler, U Keim, B Klumpp, V Heinrich, D Zips, ...
Immunotherapy 11 (4), 297-309, 2019
312019
BRAF-V600 Mutations Have No Prognostic Impact in Stage IV Melanoma Patients Treated with Monochemotherapy
D Meckbach, U Keim, S Richter, U Leiter, TK Eigentler, J Bauer, ...
PLoS One 9 (2), e89218, 2014
282014
The system can't perform the operation now. Try again later.
Articles 1–20